版本:
中国

BRIEF-Horizon Pharma says FDA approved to expand age range for Ravicti

May 1 Horizon Pharma Plc-

* Horizon Pharma Plc announces FDA approval to expand the age range for Ravicti® (glycerol phenylbutyrate) oral liquid to people with urea cycle disorders two months of age and older Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐